Tag: Insulin
Insulin Needed for T2DM Tx Set to Increase >20 Percent by 2030
Using higher HbA1c target in over-75s could increase disability-adjusted life-years by 44.2 percent
Better Glycemic Control With Closed-Loop Insulin Delivery
Better glycemic control, reduced hypoglycemia risk for T1DM patients with suboptimal glycemic control
WHO Issues Recommendations for Tx Intensification in T2DM
Also, recommendations for type of insulin for type 1 and type 2 diabetes in low-resource settings
Increasing Cost of Insulin Has Serious Health Consequences
Lowest-priced insulin required to safely, effectively achieve treatment goals should be prescribed
Basal Insulin Analogues Similar for Glucose Lowering
Slight differences in risk for nocturnal hypoglycemia or weight gain exist
Basal Insulin Analogs Don’t Cut Hypoglycemia-Linked ER Visits
No reduced risk of hypoglycemia-linked ER visits, admissions for basal insulin analog vs. NPH insulin
Circadian System, Misalignment Have Distinct Impact on Insulin
Circadian misalignment affects insulin sensitivity and insulin secretion in humans
Oral Insulin Choline, Geranate Ionic Liquid Shows Promise
Significant, sustained decrease in blood glucose levels with low insulin doses of 3 to 10 U/kg
Insulin Glargine 300 Safe, Effective in Seniors With T2DM
Significantly lower annualized rates of documented symptomatic hypoglycemia than Gla-100
ADA: Closed-Loop Insulin Improves Glycemic Control
Better glycemic control than conventional subcutaneous insulin therapy in patients with T2DM
